8-102239027-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015713.5(RRM2B):​c.-153G>T variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0419 in 760,574 control chromosomes in the GnomAD database, including 3,279 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 522 hom., cov: 31)
Exomes 𝑓: 0.044 ( 2757 hom. )

Consequence

RRM2B
NM_015713.5 upstream_gene

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.308

Publications

9 publications found
Variant links:
Genes affected
RRM2B (HGNC:17296): (ribonucleotide reductase regulatory TP53 inducible subunit M2B) This gene encodes the small subunit of a p53-inducible ribonucleotide reductase. This heterotetrameric enzyme catalyzes the conversion of ribonucleoside diphosphates to deoxyribonucleoside diphosphates. The product of this reaction is necessary for DNA synthesis. Mutations in this gene have been associated with autosomal recessive mitochondrial DNA depletion syndrome, autosomal dominant progressive external ophthalmoplegia-5, and mitochondrial neurogastrointestinal encephalopathy. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
RRM2B Gene-Disease associations (from GenCC):
  • mitochondrial DNA depletion syndrome 8a
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant progressive external ophthalmoplegia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Kearns-Sayre syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial neurogastrointestinal encephalomyopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 8-102239027-C-A is Benign according to our data. Variant chr8-102239027-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 361183.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.369 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015713.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RRM2B
NM_015713.5
MANE Select
c.-153G>T
upstream_gene
N/ANP_056528.2
RRM2B
NM_001172477.1
c.-205G>T
upstream_gene
N/ANP_001165948.1
RRM2B
NM_001172478.2
c.-153G>T
upstream_gene
N/ANP_001165949.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RRM2B
ENST00000251810.8
TSL:1 MANE Select
c.-153G>T
upstream_gene
N/AENSP00000251810.3
RRM2B
ENST00000395912.6
TSL:1
c.-153G>T
upstream_gene
N/AENSP00000379248.2
RRM2B
ENST00000519317.5
TSL:1
c.-153G>T
upstream_gene
N/AENSP00000430641.1

Frequencies

GnomAD3 genomes
AF:
0.0333
AC:
5034
AN:
150976
Hom.:
513
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00486
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0819
Gnomad ASJ
AF:
0.0274
Gnomad EAS
AF:
0.383
Gnomad SAS
AF:
0.0874
Gnomad FIN
AF:
0.0290
Gnomad MID
AF:
0.00968
Gnomad NFE
AF:
0.0115
Gnomad OTH
AF:
0.0419
GnomAD4 exome
AF:
0.0439
AC:
26778
AN:
609486
Hom.:
2757
Cov.:
8
AF XY:
0.0447
AC XY:
14391
AN XY:
321844
show subpopulations
African (AFR)
AF:
0.00459
AC:
77
AN:
16758
American (AMR)
AF:
0.104
AC:
3381
AN:
32624
Ashkenazi Jewish (ASJ)
AF:
0.0266
AC:
488
AN:
18314
East Asian (EAS)
AF:
0.357
AC:
11432
AN:
31980
South Asian (SAS)
AF:
0.0768
AC:
4628
AN:
60282
European-Finnish (FIN)
AF:
0.0296
AC:
944
AN:
31860
Middle Eastern (MID)
AF:
0.0165
AC:
44
AN:
2660
European-Non Finnish (NFE)
AF:
0.0113
AC:
4318
AN:
383232
Other (OTH)
AF:
0.0461
AC:
1466
AN:
31776
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1252
2504
3757
5009
6261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0335
AC:
5058
AN:
151088
Hom.:
522
Cov.:
31
AF XY:
0.0375
AC XY:
2766
AN XY:
73788
show subpopulations
African (AFR)
AF:
0.00485
AC:
200
AN:
41260
American (AMR)
AF:
0.0825
AC:
1255
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.0274
AC:
95
AN:
3462
East Asian (EAS)
AF:
0.383
AC:
1905
AN:
4972
South Asian (SAS)
AF:
0.0877
AC:
417
AN:
4756
European-Finnish (FIN)
AF:
0.0290
AC:
304
AN:
10486
Middle Eastern (MID)
AF:
0.00694
AC:
2
AN:
288
European-Non Finnish (NFE)
AF:
0.0115
AC:
776
AN:
67646
Other (OTH)
AF:
0.0495
AC:
104
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
187
375
562
750
937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0209
Hom.:
15
Bravo
AF:
0.0375

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 16, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Mitochondrial DNA depletion syndrome 8a Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
6.4
DANN
Benign
0.81
PhyloP100
-0.31
PromoterAI
-0.039
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2290707; hg19: chr8-103251255; COSMIC: COSV52567929; COSMIC: COSV52567929; API